Ancaron and cardiogenic shock Patient Reports February 12, 2012

Ancaron Side Effects Report #5206015-8
Ancaron side effect was reported by a Consumer or non-health professional from JAPAN on Dec 28, 2006. Male patient, 67 years of age, was diagnosed with ventricular tachycardia and was treated with Ancaron. After drug was administered, patient experienced the following side effects: brain natriuretic peptide increased, cardiac failure, cardiogenic shock, condition aggravated, haemodialysis, hepatic failure, renal failure, sepsis . Ancaron dosage: unknown. During the same period patient was treated with FAMOTIDINE, ALLOPURINOL, LASIX, ALDACTONE, WARFARIN. Patient was hospitalized. Patient died.

Ancaron Side Effects Report #6103485-8
Ancaron side effect was reported by a Health Professional from JAPAN on Feb 24, 2009. Male patient, weighting 123.5 lb, was diagnosed with ventricular tachycardia, congestive cardiomyopathy, atrial flutter, gastritis, hyperuricaemia and was treated with Ancaron. After drug was administered, patient experienced the following side effects: acidosis, cardiogenic shock, disseminated intravascular coagulation, liver disorder. Ancaron dosage: unknown. During the same period patient was treated with BLOPRESS, LASIX, TOUGHMAC E, WARFARIN, TENORMIN, GASMOTIN, ZYLORIC. Patient recovered.

Ancaron Side Effects Report #4994980-3
Ancaron side effect was reported by a Consumer or non-health professional from JAPAN on Apr 27, 2006. Male patient, 84 years of age, was diagnosed with ventricular fibrillation, ventricular tachycardia and was treated with Ancaron. After drug was administered, patient experienced the following side effects: cardiogenic shock, dialysis , pancreatitis acute. Ancaron dosage: unknown. During the same period patient was treated with PERSANTIN, OMEPRAZOLE. Patient was hospitalized. Patient died.

Ancaron Side Effects Report #5026913-8
Ancaron side effect was reported by a Consumer or non-health professional from JAPAN on June 02, 2006. Male patient, 84 years of age, was diagnosed with ventricular fibrillation, ventricular tachycardia and was treated with Ancaron. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood calcium increased, blood lactate dehydrogenase increased, cardiogenic shock, gamma-glutamyltransferase increased, pancreatitis acute. Ancaron dosage: unknown. During the same period patient was treated with PERSANTIN, OMEPRAZOLE. Patient was hospitalized. Patient died.